Financhill
Back

BioMarin Pharmaceutical, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$58.99
Seasonality Move:
5.6%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is moderately bullish and BMRN is experiencing slight selling pressure.

BioMarin Pharmaceutical, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 58.18 Buy
20-day SMA: 55.34 Buy
50-day SMA: 54.36 Buy
200-day SMA: 57.67 Buy
8-day EMA: 58.5 Buy
20-day EMA: 56.4 Buy
50-day EMA: 55.19 Buy
200-day EMA: 58.37 Buy

BioMarin Pharmaceutical, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.6 Buy
Relative Strength Index (14 RSI): 64.57 Buy
Chaikin Money Flow: -80301 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.38 - 58.4) Buy
Bollinger Bands (100): (52.66 - 57.46) Buy

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for BioMarin Pharmaceutical, Inc. Stock

Is BioMarin Pharmaceutical, Inc. Stock a Buy?

BMRN Technical Analysis vs Fundamental Analysis

Sell
49
BioMarin Pharmaceutical, Inc. (BMRN) is a Sell

Is BioMarin Pharmaceutical, Inc. a Buy or a Sell?

BioMarin Pharmaceutical, Inc. Stock Info

Market Cap:
11.5B
Price in USD:
60.04
Share Volume:
1.4M

BioMarin Pharmaceutical, Inc. 52-Week Range

52-Week High:
73.51
52-Week Low:
50.76
Sell
49
BioMarin Pharmaceutical, Inc. (BMRN) is a Sell

BioMarin Pharmaceutical, Inc. Share Price Forecast

Is BioMarin Pharmaceutical, Inc. Stock a Buy?

Fundamental Analysis of BioMarin Pharmaceutical, Inc.

Is BioMarin Pharmaceutical, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.74 per share.

Technical Analysis of BioMarin Pharmaceutical, Inc.

Should I short BioMarin Pharmaceutical, Inc. stock?

* BioMarin Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.